SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-23-271361
Filing Date
2023-11-06
Accepted
2023-11-06 16:05:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D d567247dsc13d.htm SC 13D 53502
  Complete submission text file 0001193125-23-271361.txt   54661
Mailing Address
Business Address
BLATT LAWRENCE (Filed by) CIK: 0001242110 (see all company filings)

Type: SC 13D

Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Subject) CIK: 0001799448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91770 | Film No.: 231379961
SIC: 2836 Biological Products, (No Diagnostic Substances)